1-苄基-4-苯基哌啶-4-醇 | 63843-83-4

• 物质功能分类: 分析化学 - 标准品 - 药典标准品和杂质标准品
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-苄基-4-苯基哌啶-4-醇
• 中文别名: 曲索罗地imB
• 英文名称: 1-benzyl-4-hydroxy-4-phenylpiperidine
• 英文别名: 1-benzyl-4-phenylpiperidin-4-ol；4-Hydroxy-4-phenyl-1-benzyl-piperidin
• CAS: 63843-83-4
• 化学式: C₁₈H₂₁NO
• mdl: MFCD00598510
• 分子量: 267.371
• InChiKey: FCLMXEAPEVBCKQ-UHFFFAOYSA-N

物化性质

• 熔点：
  107-109℃
• 沸点：
  176 °C(Press: 0.1 Torr)
• 密度：
  1.135

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P501,P270,P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313,P301+P312+P330
• 危险性描述：
  H302,H315,H319

反应信息

• 作为反应物：
  描述：

  1-苄基-4-苯基哌啶-4-醇 在 三氯化铝 作用下， 反应 2.5h， 生成 1-Ethoxycarbonyl-4,4-diphenylpiperidin
  参考文献：
  名称：

  Schaefer; Hackmack; Eistetter, Arzneimittel-Forschung/Drug Research, 1984, vol. 34, # 3, p. 233 - 240

  摘要：

  DOI：
• 作为产物：
  描述：

  4-哌啶酮 在 potassium carbonate 、 magnesium 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 反应 20.17h， 生成 1-苄基-4-苯基哌啶-4-醇
  参考文献：
  名称：

  Structure-guided design and synthesis of P1′ position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors

  摘要：

  Previously, we reported potent pentapeptidic BACE1 inhibitors with the hydroxymethylcarbonyl isostere as a substrate transition-state mimic. To improve the in vitro potency, we further reported pentapeptidic inhibitors with carboxylic acid bioisosteres at the P-4 and P-1' positions. In the current study, we screened new P-1' position 1-phenylcycloalkylamine analogs to find non-acidic inhibitors that possess double-digit nanomolar range IC50 values. An extensive structure-activity relationship study was performed with various amine derivatives at the P-1' position. The most potent inhibitor of this pentapeptide series, KMI-1830, possessing 1-phenylcyclopentylamine at the P-1' position had an IC50 value of 11.6 nM against BACE1 in vitro enzymatic assay. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.07.002

文献信息

• Shuttle arylation by Rh(I) catalyzed reversible carbon–carbon bond activation of unstrained alcohols
  作者：Marius D.R. Lutz、Valentina C.M. Gasser、Bill Morandi

  DOI：10.1016/j.chempr.2021.02.029

  日期：2021.4

  transfer hydrogenation and borrowing hydrogen reactions paved the way to manipulate simple alcohols in previously unthinkable manners and circumvented the need for hydrogen gas. Analogously, transfer hydrocarbylation could greatly increase the versatility of tertiary alcohols. However, this reaction remains unexplored because of the challenges associated with the catalytic cleavage of unactivated C–C bonds

  转移氢化和借用氢反应的出现为以以前无法想象的方式操作简单的醇铺平了道路，并避免了对氢气的需求。类似地，转移烃基化可以大大提高叔醇的多功能性。然而，由于与未活化的CC键的催化裂解有关的挑战，该反应仍未得到探索。在本文中，我们报道了铑（I）催化的穿梭芳基化反应，通过氧化还原中性β-碳消除机制，在未应变的三芳基醇中裂解C（sp 2）-C（sp 3）键。使用良性醇作为潜在的C，实现了从叔醇到酮的取代（杂）芳基的选择性转移烃基化-亲核试剂。所有初步的机械实验都支持可逆的β-碳消除/迁移插入机制。在更广泛的背景下，这种新颖的反应性为催化叔醇的操作提供了新的平台。
• Synthesis of Haloperidol Ethanedithioketal HIV-1 Protease Inhibitors: Magnesium Chloride Facilitated Addition of Grignard Reagents
  作者：Zhihua Sui、James J. De Voss、Dianne L. Decamp、Jia Li、Charles S. Craik、Paul R. Ortiz de Montellano

  DOI：10.1055/s-1993-25946

  日期：——

  Haloperidol ketals and ethanedithioketals of interest as HIV-1 protease inhibitors were synthesized by addition of organolithium and organomagnesium reagents to ketone precursors already containing the ketal or thioketal functionality. Addition of Grignard reagents to the thioketal containing ketone was enhanced remarkably, and to the ketal containing ketone moderately, by the addition of magnesium chloride. The effect of magnesium chloride is attributed to its ability to competitively prevent chelation of the Grignard reagent and proton abstraction from the 4-oxopiperidine ring. The biological activities of the ketals and thioketals indicate that the thioketal function conveys greater ability to inhibit the HIV-1 protease than the ketal function.

  作为HIV-1蛋白酶抑制剂的有趣的羟哌啶酮酮缩醇和对苯二甲硫酮，通过将有机锂和有机镁试剂添加到已经含有酮缩醇或硫酮功能的酮前体来合成。向含有硫酮的酮中添加Grignard试剂的反应显著增强，而对含有酮缩醇的酮则适度增强，这是通过添加氯化镁实现的。氯化镁的影响归因于它竞争性地防止Grignard试剂的螯合和从4-氧哌啶环上的质子抽取。酮缩醇和硫酮的生物活性表明，硫酮功能比酮缩醇功能具有更强的抑制HIV-1蛋白酶的能力。
• A novel modification of the Ritter reaction using trimethylsilyl cyanide
  作者：H.G. Chen、O.P. Goel、S. Kesten、J. Knobelsdorf

  DOI：10.1016/0040-4039(96)01890-4

  日期：1996.11

  A new modification of the Ritter reaction using trimethylsilyl cyanide (Me3SiCN) is described, which converts alcohols to their corresponding formamides in high yields using a convenient procedure. The reaction conditions and mechanism are discussed. In some cases, new formamides are synthesized which cannot be prepared by the classical Ritter reaction.

  描述了使用三甲基甲硅烷基氰化物（Me 3 SiCN）对Ritter反应进行的新修饰，该修饰可以使用方便的方法以高收率将醇转化为其相应的甲酰胺。讨论了反应条件和机理。在某些情况下，会合成无法通过经典的Ritter反应制备的新甲酰胺。
• A Practical Synthesis of tert-Alkylamines via the Ritter Reaction with Chloroacetonitrile
  作者：Aigars Jirgensons、Valerjans Kauss、Ivars Kalvinsh、Markus R. Gold

  DOI：10.1055/s-2000-8208

  日期：——

  Ritter reaction of tertiary alcohols with chloroacetonitrile and subsequent cleavage of chloroacetyl group in the resulting chloroacetamide with thiourea is an efficient procedure for synthesis of tert-alkylamines.

  三烷基胺的高效合成步骤涉及使用氯乙腈与三级醇进行里特反应，随后在生成的氯乙酰胺中用硫脲裂解氯乙酰基团。
• [EN] HEPATITIS B ANTIVIRAL AGENTS<br/>[FR] AGENTS ANTIVIRAUX DE L'HÉPATITE B
  申请人：NOVIRA THERAPEUTICS INC

  公开号：WO2013096744A1

  公开（公告）日：2013-06-27

  The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

  本发明包括一种抑制、压制或预防需要的人体内HBV感染的方法，包括向个体投给治疗有效量的至少一种本发明的化合物。